疑似冠心病患者心肌血流储备与冠状动脉钙化的预后价值
本研究纳入4008例因疑似冠心病行PET心肌灌注显像并计算冠状动脉钙化(CAC)评分的连续患者,主要终点为心源性死亡和非致死性心肌梗死复合终点。中位随访1.9年,CAC和心肌血流储备(MFR)均在临床和灌注变量基础上提供增量预后价值,但两者联合未进一步增强风险预测。
要点
- CAC和MFR均在临床及PET灌注变量基础上提供独立增量预后价值。
- CAC模型c-index 0.8330,MFR模型c-index 0.8279,均优于基础模型0.8137。
- CAC与MFR联合未显著优于单独CAC或单独MFR模型。
核心结论
- 在因疑似冠心病行PET心肌灌注显像的大队列中,CAC和MFR均在临床和MPI变量基础上独立提供增量预后价值。
- 两者联合可能具有协同预后效应,但本分析的多变量模型未显示该关系。
研究设计与样本
- 研究类型为连续患者队列分析,样本量4008例,来自沙特阿拉伯利雅得King Abdulaziz心脏中心,纳入时间为2011年5月至2018年5月。
- 所有患者在同一设置下接受PET MPI和CAC评分计算,主要终点为心源性死亡和非致死性心肌梗死复合终点。
- 采用Cox比例风险回归,通过序贯将CAC和MFR变量加入包含临床和PET变量的模型来评估增量预后价值。
关键影像表现/征象
- 队列中35.9%的患者CAC为0,16.5%的患者CAC≥400,43.9%的患者MFR<2。
- 中位随访1.9年期间,130例(3.2%)患者发生心源性死亡或非致死性心肌梗死。
诊断标准与关键数值
- CAC以CAC≥400和CAC=0作为分布描述,MFR以<2作为异常阈值描述。
- 基础模型(临床+灌注变量)c-index 0.8137,AIC 1,865.877。
- CAC模型c-index 0.8330,AIC 1,850.810,与基础模型比较p=0.045。
- MFR模型c-index 0.8279,AIC 1,859.235,与基础模型比较p=0.024。
- CAC+MFR联合模型c-index 0.8435,AIC 1,846.334,与MFR模型比较p=0.074,与CAC模型比较p=0.21。
临床应用与阅片要点
- 在PET MPI报告中,除灌注变量外,可结合CAC评分和MFR进行风险分层。
- CAC和MFR各自提供增量预后信息,联合使用在本分析中未显示显著额外获益。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: The aim of this analysis is to examine the incremental prognostic value of coronary artery calcium (CAC) score and myocardial flow reserve (MFR) in patients with suspected coronary artery disease (CAD) undergoing positron emission tomography (PET) myocardial perfusion imaging (MPI).
BACKGROUND: Advances in cardiac PET and computed tomography imaging enabled the simultaneous acquisition of anatomic and physiological data for patients suspected of CAD.
METHODS: Consecutive patients who underwent PET MPI and CAC score calculation at King Abdulaziz Cardiac Center, Riyadh, Saudi Arabia, between May 2011 and May 2018 were included in the study. MPI and CAC images were obtained in the same setting. The primary endpoint of the study was a composite of cardiac death and nonfatal myocardial infarction. Cox proportional hazard regression was used to assess the incremental prognostic value of CAC and MFR by sequentially adding the variables to a model that included clinical and PET variables.
RESULTS: A total of 4,008 patients (mean age 59.7 ± 11.6 years, 55% women) were included in the analysis. Risk factors were prevalent (77.6% hypertension, 58.1% diabetes). In total, 35.9% of the cohort had CAC of 0, 16.5% had CAC ≥400, and 43.9% had MFR <2. Over a median follow up of 1.9 years, 130 (3.2%) patients had cardiac death/nonfatal myocardial infarction. CAC and MFR score added incremental prognostic value over clinical and perfusion variables (base model: c-index 0.8137; Akaike information criterion [AIC]: 1,865.877; p = 0.0011; CAC model: c-index = 0.8330; AIC: 1,850.810; p = 0.045 vs. base model; MFR model: c-index = 0.8279; AIC: 1,859.235; p = 0.024). Combining CAC and MFR did not enhance risk prediction (c-index = 0.8435; AIC: 1,846.334; p = 0.074 vs. MFR model; p = 0.21 vs. CAC model.) CONCLUSIONS: In this large cohort of patients referred for PET MPI, both CAC and MFR independently added incremental prognostic value over clinical and MPI variables. Although combining both may have synergetic prognostic effect, this relation was not shown in multivariable model of this analysis.
引用
- Aljizeeri A, Ahmed AI, Alfaris MA, et al. Myocardial Flow Reserve and Coronary Calcification in Prognosis of Patients With Suspected Coronary Artery Disease. JACC Cardiovasc Imaging. 2021. PMID: 33744156. doi:10.1016/j.jcmg.2021.01.024
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。